PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go:
Stretch
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Clinical Net is a health-tech firm focused on revolutionizing access to innovative clinical trials. Their AI platform swiftly connects patients with suitable trials, addressing the challenge of low participation rates and delays that hinder pharmaceutical research. With over 69,000 trials globally, their solution aims to streamline the cumbersome and time-consuming process of trial matching, making it more efficient and accessible within 5 minutes. This innovative approach targets the $3.73 billion patient recruitment market while ensuring individuals have easier access to groundbreaking treatments.
days to go:
Expired
investment:
£136,827
Agile Store Builder allows you create your very own worldwide network of multiple stores by country, language, domain and product. These are all collectively managed in one system. You can also create stores for partners and affiliates to sell your products on a commission basis.
days to go:
Expired
investment:
£261
Infinity Circle (IC) is a digital wealth creation platform that aims to create an ecosystem where wealth management meets social media in a way that is cyber secure, respects a user's privacy, and complies with the Financial Conduct Authority's (FCA) rules. IC intends to vet and distribute the best-in-class products for each asset class on its platform that is planned to be partly automated and partly operated by specialists who can guide a user. IC asserts that its CEO Elisabeth Dana has worked with the likes of Barclays Private Wealth, handling average accounts of £50 million while its CTO, Ashley Adkins, is a coding expert who has put his talent at the service of the UK Government before starting his private practice. It will use 40% of the investment for technology innovation, 30% for upgrading operations, and 30% to market the platform's launch.
days to go:
Expired
investment:
£335,390
ShareProperty is a property crowdfunding platform that allows you, the investor to select your investment according to your own risk profile and required rate of return. ShareProperty allows you to build and manage your own property portfolio, hold your investment to term or resell on the ShareProperty trading exchange.
days to go:
Expired
investment:
£149,002
Love2move has developed a platform to bridge the gap between sellers/ homeowners and the market. It functions as an internet estate agent working in collaboration with well- established estate agents with a physical office. This way Love2move provides its users the best of both traditional as well as online estate agents. With the help of online sales platform, the agents can list homes without much setup costs involved.
days to go:
Expired
investment:
£51,850
TransferGuru is a money transfer comparison site that aims to get the best deal possible for people transfering money abroad. The user simply inputs the amount they want to send and where they want it to go and they will then be shown all the options, displaying the best price, the best ratings and the fastest way to make the transfer.
days to go:
Expired
investment:
£82,593
